AAAAAA
Results: 1-25/41
Authors:
Weir, MR
Citation: Mr. Weir, Appropriate use of calcium antagonists in hypertension, HOSP PRACT, 36(9), 2001, pp. 47
Authors:
Weir, MR
Henrich, WL
Citation: Mr. Weir et Wl. Henrich, Hypertension in patients with type 2 diabetes, HOSP PRACT, 36(1), 2001, pp. 41
Authors:
Weir, MR
Blantz, RC
Citation: Mr. Weir et Rc. Blantz, Implications from the heart outcomes prevention evaluation study, CURR OP NEP, 10(1), 2001, pp. 61-63
Authors:
Weir, MR
Rosenberger, C
Fink, JC
Citation: Mr. Weir et al., Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists, AM J HYPERT, 14(9), 2001, pp. 963-968
Authors:
Weir, MR
Weber, MA
Neutel, JM
Vendetti, J
Michelson, EL
Wang, RY
Citation: Mr. Weir et al., Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: A clinical experience trial, AM J HYPERT, 14(6), 2001, pp. 567-572
Authors:
Weir, MR
Citation: Mr. Weir, Diabetes and hypertension: How low should you go and with which drugs?, AM J HYPERT, 14(5), 2001, pp. 17S-26S
Authors:
Wang, QK
Matsuura, T
Feng, CY
Weir, MR
Detellier, C
Rutadinka, E
Van Mao, RL
Citation: Qk. Wang et al., The sepiolite membrane for ultrafiltration, J MEMBR SCI, 184(2), 2001, pp. 153-163
Authors:
Weir, MR
Rutinduka, E
Detellier, C
Feng, CY
Wang, Q
Matsuura, T
Le Van Mao, R
Citation: Mr. Weir et al., Fabrication, characterization and preliminary testing of all-inorganic ultrafiltration membranes composed entirely of a naturally occurring sepioliteclay mineral, J MEMBR SCI, 182(1-2), 2001, pp. 41-50
Authors:
Fink, JC
Salmanullah, M
Blahut, SA
Weir, MR
Sawyer, R
Henrich, WL
Hise, MK
Citation: Jc. Fink et al., The inevitability of renal function loss in patients with hypercreatinemia, AM J NEPHR, 21(5), 2001, pp. 386-389
Authors:
Weir, MR
Ward, MT
Blahut, SA
Klassen, DK
Cangro, CB
Bartlett, ST
Fink, JC
Citation: Mr. Weir et al., Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy, KIDNEY INT, 59(4), 2001, pp. 1567-1573
Authors:
Land, W
Weir, MR
Citation: W. Land et Mr. Weir, Approaches to improve allograft half-life III: Practical aspects of sparing and switching maneuvers - Foreword, TRANSPLAN P, 33(4), 2001, pp. 1S-1S
Authors:
Weir, MR
Citation: Mr. Weir, Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation, TRANSPLAN P, 33(4), 2001, pp. 19S-28S
Authors:
Wiland, AM
Fink, JC
Philosophe, B
Farney, AC
Schweitzer, EJ
Colonna, JO
Weir, MR
Bartlett, ST
Citation: Am. Wiland et al., Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1910-1910
Authors:
Hadley, GA
Charandee, C
Weir, MR
Wang, D
Bartlett, ST
Drachenbere, CB
Citation: Ga. Hadley et al., CD103+CTL accumulate within the graft epithelium during clinical renal allograft rejection, TRANSPLANT, 72(9), 2001, pp. 1548-1555
Authors:
Nogueira, JM
Fink, JC
Weir, MR
Citation: Jm. Nogueira et al., Recipient outcome after receiving a laparoscopically harvested kidney froma living donor, TRANSPLANT, 72(2), 2001, pp. 355-356
Authors:
Konstam, MA
Weir, MR
Reicin, A
Shapiro, D
Sperling, RS
Barr, E
Gertz, BJ
Citation: Ma. Konstam et al., Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib, CIRCULATION, 104(19), 2001, pp. 2280-2288
Authors:
Weir, MR
Citation: Mr. Weir, Choosing the first agent, CUR CL PRAC, 2001, pp. 209-221
Authors:
Weir, MR
Henrich, WL
Citation: Mr. Weir et Wl. Henrich, Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers, CURR OP NEP, 9(4), 2000, pp. 403-411
Authors:
Chrysant, SG
Weder, AB
McCarron, DA
Canossa-Terris, M
Cohen, JD
Gunter, PA
Hamilton, BP
Lewin, AJ
Mennella, RF
Kirkegaard, LW
Weir, MR
Weinberger, MH
Citation: Sg. Chrysant et al., Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake, AM J HYPERT, 13(11), 2000, pp. 1180-1188
Authors:
Fink, JC
Weir, MR
Citation: Jc. Fink et Mr. Weir, Untitled - Reply, AM J KIDNEY, 35(3), 2000, pp. 562-562
Authors:
Klassen, DK
Drachenberg, CB
Papadimitriou, JC
Cangro, CB
Fink, JC
Bartlett, ST
Weir, MR
Citation: Dk. Klassen et al., CMV allograft pancreatitis - Diagnosis, treatment, and histological features, TRANSPLANT, 69(9), 2000, pp. 1968-1971
Authors:
Weir, MR
Citation: Mr. Weir, When antihypertensive monotherapy fails: Fixed-dose combination therapy, SOUTH MED J, 93(6), 2000, pp. 548-556
Authors:
Bakris, GL
Weir, MR
Citation: Gl. Bakris et Mr. Weir, Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?, ARCH IN MED, 160(5), 2000, pp. 685-693
Authors:
Weir, MR
Maibach, EW
Bakris, GL
Blach, HR
Chawla, P
Messerli, FH
Neutel, JM
Weber, MA
Citation: Mr. Weir et al., Implications of a health lifestyle and medication analysis for improving hypertension control, ARCH IN MED, 160(4), 2000, pp. 481-490
Authors:
Weir, MR
Moser, M
Citation: Mr. Weir et M. Moser, Diuretics and beta-blockers: Is there a risk for dyslipidemia?, AM HEART J, 139(1), 2000, pp. 174-184